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Abstract 
Background: Engineering of single-species biofilms for enzymatic generation of fine chemicals is attractive. We have 
recently demonstrated the utility of an engineered Escherichia coli biofilm as a platform for synthesis of 5-halotrypto-
phan. E. coli PHL644, expressing a recombinant tryptophan synthase, was employed to generate a biofilm. Its rapid 
deposition, and instigation of biofilm formation, was enforced by employing a spin-down method. The biofilm pre-
sents a large three-dimensional surface area, excellent for biocatalysis. The catalytic longevity of the engineered bio-
film is striking, and we had postulated that this was likely to largely result from protection conferred to recombinant 
enzymes by biofilm’s extracellular matrix. SILAC (stable isotopic labelled amino acids in cell cultures), and in particular 
dynamic SILAC, in which pulses of different isotopically labelled amino acids are administered to cells over a time 
course, has been used to follow the fate of proteins. To explore within our spin coated biofilm, whether the recombi-
nant enzyme’s longevity might be in part due to its regeneration, we introduced pulses of isotopically labelled lysine 
and phenylalanine into medium overlaying the biofilm and followed their incorporation over the course of biofilm 
development.
Results: Through SILAC analysis, we reveal that constant and complete regeneration of recombinant enzymes occurs 
within spin coated biofilms. The striking catalytic longevity within the biofilm results from more than just simple 
protection of active enzyme by the biofilm and its associated extracellular matrix. The replenishment of recombinant 
enzyme is likely to contribute significantly to the catalytic longevity observed for the engineered biofilm system.
Conclusions: Here we provide the first evidence of a recombinant enzyme’s regeneration in an engineered biofilm. 
The recombinant enzyme was constantly replenished over time as evidenced by dynamic SILAC, which suggests 
that the engineered E. coli biofilms are highly metabolically active, having a not inconsiderable energetic demand. 
The constant renewal of recombinant enzyme highlights the attractive possibility of utilising this biofilm system as a 
dynamic platform into which enzymes of interest can be introduced in a “plug-and-play” fashion and potentially be 
controlled through promoter switching for production of a series of desired fine chemicals.
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Background
The development of novel biocatalysts is crucial in order 
to provide greener and more sustainable solutions for 
synthesis of fine chemicals. Enzymatic transformations 
are becoming increasingly important to the chemical 
manufacturing and pharmaceutical industries and it is 
projected that by 2050, in order to move toward greater 
sustainability and cost reduction, 30 % of chemical syn-
theses in these sectors will be biocatalytic [1, 2]. One 
significant challenge to reaching this goal is that many 
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enzymes demonstrate poor stability. Whilst immobili-
zation technologies have been successfully utilised to 
improve enzyme viability and allow catalyst recycling 
[3–13], and evolution approaches have been success-
fully employed to afford enhanced stability [14–25], 
these approaches must be applied and optimised for each 
enzyme on a case-by-case basis and can add significant 
overall cost to the biocatalytic process. Whole cell bio-
catalysts offer a useful alternative to the use of isolated 
enzymes, especially for processes requiring the recycling 
of expensive cofactors [26–37], yet these biocatalysts are 
not able to operate for prolonged periods of time due to 
substrate and/or product toxicity and constant exposure 
to physical and chemical extremes, i.e. shear stress, high 
temperature, pH variation or solvents. This has driven 
the need to optimize a given whole-cell process, such 
as immobilization of cells which provide a more stable 
environment and the benefit of easy retrieval for reuse 
[29, 35, 38–45]. In contrast, the naturally immobilized 
cells or biofilms representing the predominant microbial 
lifestyle in the natural environment are well known for 
their resilience [46–51]. Their robustness, which in part 
is conferred by a well-organized 3-dimensional architec-
ture where cells are embedded and protected by a matrix 
of secreted extracellular polymeric substances (EPS), 
allows them to withstand unfavourable conditions that 
planktonic cells and immobilised enzymes are not able 
to tolerate [52–56]. These properties lend them to being 
stable biocatalysts of utility to various industrial sectors: 
biofilms, mainly multi-species communities of bacteria, 
are employed in waste water treatment and bioreme-
diation of polluted sites [57–61], and single species bio-
films are used for the sustainable production of simple 
compounds, such as acetic acid, ethanol, butane-2,3-diol 
and succinic acid [60, 62, 63]. Recently, there is a grow-
ing interest in developing and utilising biofilm-based 
processes, and a new area of utilising engineered sin-
gle species biofilms for synthesis of desired fine chemi-
cals is beginning to emerge [64–70]. The utilisation of E. 
coli biofilms is attractive due to the wide industrial use 
of E. coli and the ease with which it can be genetically 
manipulated, e.g., overexpressing genes encoding target 
enzymes and constructing knockout mutants for control 
and maximization of target products and elimination of 
by-products. Previously we have demonstrated how the 
process of biofilm generation and maturation by E. coli 
K-12 PHL644, which readily forms biofilms due to over-
production of the adhesin curli [71], could be artificially 
accelerated by simply spinning cells onto glass plates 
coated with poly-l-lysine [65]. After 6  days maturation 
of the engineered biofilm, well-organised mushroom-like 
structures are visible where cells are arranged in multi-
layers and embedded in the biofilm extracellular matrix. 
Deep pores and channels developed, conferring a large 
catalytic surface area to the biofilm [65, 72]. We previ-
ously showed that this system could be engineered by 
constitutive expression of the tryptophan synthase from 
Salmonella enterica (TrpBA) encoded by plasmid pSTB7 
[73]. The recombinant TrpBA is composed of two subu-
nits associated as an α2β2 tetramer, and the β subunit is 
catalytically independent, mediating the synthesis of 
l-tryptophan from free indole and l-serine. The engi-
neered biofilm has been employed to catalyse the enan-
tio-selective conversion of haloindoles and l-serine to 
l-halotryptophans, a series of fine chemicals of value in 
the synthesis of medicinally relevant compounds [65, 70]. 
We previously observed that in the biotransformation of 
5-chloroindole to 5-chlorotryptophan, strikingly, higher 
conversions were obtained with the 7  day-old biofilm 
(conversions of 78 %) than with the immobilised TrpBA 
enzyme (conversions of 49 %) or planktonic cells express-
ing recombinant TrpBA (conversions of 40 %) [65]. It was 
also notable, in our previous experiments, that biotrans-
formation of 5-chloroindole to 5-chlorotryptophan with 
the engineered biofilm still proceeded at the initial rate 
following 30 h incubation (Additional file 1: Figure S1a) 
[65]. Moreover, the biofilm could be reused and, remark-
ably, there was no observable decrease in catalytic activ-
ity after three sequential reaction cycles (Additional file 1: 
Figure S1b) [65]. Intrigued by the promising catalytic lon-
gevity and the potential application of this biofilm system 
in catalysing a range of required biotransformations, as 
simple to engineer, plug and play biocatalysts, we sought 
to investigate the reason for the observed biocatalytic 
longevity further. Through a pulse-chase SILAC (stable 
isotope labelling by amino acids in cell cultures) study, 
we set out to explore the fate of the recombinant enzyme 
introduced to the biofilm as a catalyst. Our aim was to 
investigate whether the catalytic longevity of the biofilm 
is in part due to the regeneration of the recombinant bio-
catalytic enzyme, beyond the protection conferred by the 
EPS.
Results and discussion
Application of pulse‑chase SILAC to follow the fate of the 
recombinant enzyme expressed in the biofilm
Pulse-chase SILAC experiments involve dynamically fol-
lowing the metabolic behaviour of a cell culture in the 
presence of an isotopically labelled amino acid, followed 
by media replacement and the growth of the culture in 
the presence of the unlabelled amino acid. In this case we 
wished to explore whether the production of the recom-
binant enzyme tryptophan synthase was continuous, 
in engineered biofilms. In a typical SILAC experiment, 
at given time points, cells are harvested for preparation 
of protein samples and target proteins are isolated and 
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tracked for label incorporation. Lysine and arginine are 
the most commonly used labelled amino acids for these 
studies as they present a trypsin cleavage site (provided 
they are not followed by a proline residue) and a conveni-
ent C terminal label for mass spectrometry (MS) analy-
sis [74, 75]. Other stable isotope labelled amino acids 
are also frequently used [76] and the choice is usually 
dictated by the abundance of each amino acid in the pro-
tein under investigation. Importantly, the labelled form 
of the peptides resulting from the trypsin digestion of 
the parent protein must have a distinct mass, compared 
to the unlabelled peptide pool in order to be detected in 
the MS analysis. The optimal additional mass conferred 
by an isotopically labelled amino acid is plus 4 Da, when 
exploring expression profiles of a complex series of differ-
ent proteins or an entire proteome [74]. However, when 
exploring a single protein, the additional mass of plus 
2 Da per amino acid incorporated is more than sufficient 
to enable ready detection of incorporation, as, for a dou-
bly charged peptide fragment, the incorporation of such 
a label would result in an increase of 1  Da in the m/z. 
Conventional SILAC analysis involves a single pulse of 
one isotopically labelled amino acid followed by a single 
chase [76–78]. However, to gain a greater understanding 
of our biofilm and whether it regenerates its recombinant 
biocatalytic enzyme over the course of its maturation, 
we designed a multistep labelling regiment using a series 
of two labelled and unlabelled amino acids. To ascertain 
which two labelled amino acids should be utilised in the 
SILAC experiment, the amino acid composition and the 
tryptic digest of the β subunit of TrpBA were evaluated 
in silico (summarised in Additional file 1: Tables S1, S2, 
respectively). In TrpBA, lysine and phenylalanine are 
abundant, at around 5 and 3 % of all amino acids. Of the 
unique tryptic peptides with five or more amino acids, 
71 % contain lysine and 33 % contain phenylalanine. Due 
to the observation of a high frequency of occurrence 
of lysine in the tryptic peptides of TrpBA, we therefore 
chose to use [4,4,5,5-2H4]-l-lysine as the SILAC amino 
acid. We chose [2,6-2H2]-l-phenylalanine as the second 
labelled amino acid due to our ability to generate the iso-
topic phenylalanine in plentiful supply, in a cost effective 
manner, in house. Growing the biofilm in the presence of 
each of these labels would provide an anticipated shift of 
2 m/z unit per each [4,4,5,5-2H4]-l-lysine residue incor-
porated and a shift of 1  m/z unit per each [2,6-2H2]-
l-phenylalanine residue.
To provide statistically robust results, in order to 
explore definitively whether the recombinant enzyme 
in the biofilm was regenerated, six series of pulse-chase 
experiments were carried out, in triplicate, as summa-
rised in Fig. 1 (full details provided in the Methods sec-
tion). Our labelling regimen involved supplementation of 
sets of individual cultures of the E. coli cells, to be used in 
biofilm formation, each with one of the two isotopically 
labelled amino acids. After the cultures had grown in the 
presence of the label, these cells were spin-coated onto 
glass slides that were then placed within deep-well plates, 
in the same manner as we have previously reported for 
the promotion of rapid biofilm formation [65]. Fresh 
media containing the same labelled amino acid (either 
labelled lysine or phenylalanine), as the cultures had been 
initiated in, was reintroduced to each well, and then incu-
bated for 3  days whilst the biofilms started to mature. 
After 3  days the medium was removed and replaced 
with fresh media supplemented now with the unlabelled 
variant of the initial amino acid that had been used for 
each culture/biofilm i.e. unlabelled phenylalanine (Fig. 1, 
rows 2, 3) or unlabelled lysine (Fig. 1, rows 5, 6). The bio-
films from both rows 1 and 4 were harvested for prepa-
ration of target proteins subjected to tryptic digestion 
followed by liquid chromatography-mass spectrometry 
(LC–MS) analysis (as detailed in the ‘‘Methods’’ section). 
After a further 3 days of maturation, biofilms in rows 2 
and 5 were harvested and processed for downstream 
analysis. Again, the media were removed from all of the 
other biofilms, and the isotopic labelling regimen was 
swapped with the biofilm in row 3, that had previously 
been cultured in the presence firstly of deuterated then 
unlabelled phenylalanine now being supplemented with 
labelled lysine. Conversely, the biofilm in row 6 that had 
previously being supplemented firstly with labelled then 
unlabelled lysine, now being supplemented with labelled 
phenylalanine. The incubation continued until day 9 with 
biofilms in rows 3 and 6 being harvested at this stage.
Identifying and quantifying peptides from SILAC samples 
reveals the replenishment of the recombinant biocatalytic 
enzyme within the biofilm
As described above, and in Fig. 1, we designed a labelling 
regime which included pulsing with labelled amino acids, 
followed by a chase phase in which unlabelled amino 
acids, then an alternative labelled amino acid was admin-
istered to maturing biofilms. At each time point, where 
the label was changed (as illustrated in Fig.  1) biofilms 
were harvested for preparation of target proteins sub-
jected to tryptic digestion, and the tryptic peptides were 
submitted for LC–MS analyses. The MS data were ana-
lysed using the Mascot algorithm (Matrix Science, Lon-
don, UK) [79] with the modified masses of SILAC amino 
acids, i.e., [2,6-2H2]-l-phenylalanine and [4,4,5,5-2H4]-
l-lysine, added as variable modifications in the searches 
against an internal database at the BSRC (Biological Sci-
ence Research Complex, University of St Andrews, UK). 
The data were also searched against the National Centre 
for Biotechnology Information (NCBI) database [80]. The 
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fragments of the β subunit of TrpBA identified by Mas-
cot, based on at least five biofilm samples, are listed in 
Additional file  1: Table S3. In total, the identified frag-
ments covered 53 % of all amino acids of TrpBA.
The aim of pulse-chase SILAC experiment performed 
in this study is to evaluate whether the recombinant 
enzyme expressed in the biofilm is replenished over time; 
if the system is static and the catalytic longevity is sim-
ply due to the protection of the initial enzyme popula-
tion, little change or no incorporation in the label would 
be expected for target proteins coming from biofilms 
after 6 days of maturation. If the engineered biofilm ena-
bles catalytic longevity by renewal of the enzyme and 
the system is highly dynamic we would anticipate an 
observation of a change in the incorporation level of the 
respective labelled amino acid, at 6  days of maturation 
and beyond. After peptide identification, the MS spectra 
and ion chromatograms of two tryptic peptides (VGI-
YFGMK and DPEFQAQFADLLK) from the β subunit 
of TrpBA were extracted and examined at the MS level 
to quantify the incorporation level of each SILAC amino 
acid (the distribution of two peptides along the protein 
sequence is depicted in Additional file 1: Figure S2). The 
signal intensities (areas under the curves) from light and 
heavy peptides provide a quantitative comparison of 
their relative abundances [75, 78, 81]. The MS spectra of 
two reference peptides, which each gave nearly identical 
quantification results, are provided in Additional file  1: 
Figures S3, S4.
We examined the incorporation level of SILAC amino 
acid into target proteins from biofilm samples harvested 
at each time point (day 3, day 6 and day 9). The level of 
incorporation was quantified by calculating the median 
of the labelled (heavy, H)/unlabelled (light, L) ratios 
according the accepted procedure [78]. In accordance 
with this standard literature procedure for determination 
of the median of H/L peptide ratios, the peak areas of 
the extracted ion chromatograms (XICs) of the labelled 
peptides were measured against the unlabelled peptides. 
The degree of labelling on target protein was quantified 
with two reference peptides, as listed above (see Addi-
tional file 1: Figures S5, S6 for the XICs of the two pep-
tides). Labelling analysis of the recombinant tryptophan 
synthase produced by 3 day-old biofilms showed isotopic 
incorporation levels of ~93 % for biofilms that had been 
cultured in minimal M63 medium supplemented with 
[2,6-2H2]-l-phenylalanine (Fig.  1, row 1 samples), and 
isotopic incorporation levels of about 38  % for biofilms 
Fig. 1 Workflow for the pulse-chase SILAC experiment. For biofilm generation, E. coli PHL644 cells in stationary phase were spun down onto poly-
l-lysine coated slides placed in 9-deep-well plates. Triplicate sets of biofilms were initially matured in minimal M63 media supplemented with either 
[2,6-2H2]-l-phenylalanine (rows 1-3, filled blue circles) or [4,4,5,5-
2H4]-l-lysine (rows 4–6, filled orange circles). After 3 days of maturation, biofilms from 
rows 1, 4 were harvested (as denoted by the crosses) to prepare protein samples. Labelled media were replaced with fresh unlabelled media (empty 
blue circles for l-phenylalanine and empty orange circles for l-lysine) for the chase phase. Following a further 3 days of incubation, the biofilms in rows 
2, 5 that had matured for 6 days were harvested to extract proteins. The media of the remaining biofilms was again exchanged; fresh media con-
taining [2,6-2H2]-l-phenylalanine were provided to the biofilms that had been previously supplemented with lysine, and conversely fresh labelled 
media supplemented with [4,4,5,5-2H4]-l-lysine were provided to the biofilms that had previously been supplemented with phenylalanine. At day 9, 
biofilms from rows 3 and 6 were harvested
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that had matured in [4,4,5,5-2H4]-l-lysine supplemented 
medium (Fig. 1, row 4 samples). The lower incorporation 
level of deuterated l-lysine was observed, even though 
supplemented at ten-fold higher concentration, poten-
tially due to the direction of this amino acid towards 
alternative metabolic pathways, and highlights the ben-
efits of utilising a pair of labelled amino acids.
To evaluate whether fresh enzymes were produced in 
both sets of samples, as described above, after 3  days 
maturation of the engineered biofilm we started the chas-
ing by replacing the labelled medium with fresh medium 
supplemented with the respective unlabelled amino 
acids (Fig. 1, rows 2, 3 for phenylalanine and rows 5, 6 for 
lysine). After 3 more days of maturation, biofilms from 
rows 2 and 5 chased with unlabelled phenylalanine and 
lysine respectively, were harvested for preparation of tar-
get proteins. As seen in Fig. 2, for the row 2 samples, it 
was observed that the incorporation level of deuterated 
l-phenylalanine had dropped from 93 to 10  %; for the 
row 5 samples, the incorporation level of [4,4,5,5-2H4]-
l-lysine was also observed to decrease from 38 to 16 %. 
The reduced level of SILAC amino acids observed for 
three reference peptides suggests that new recombi-
nant enzyme was dynamically generated de novo. We 
also examined the MS spectra of two reference peptides, 
detected from the tryptic digest of recombinant enzyme 
coming from the biofilms chased with unlabelled phe-
nylalanine (Additional file  1: Figures S3, S4; row 2) or 
unlabelled lysine (Additional file  1: Figures S3, S4; row 
5). A drop in the incorporation level of the stable isotope 
Fig. 2 Summary of changes in the incorporation level of SILAC amino acids into target protein. The labelling efficiency is calculated based on 
the XICs of the two peptides, VGIYFGMK and DPEFQAQFADLLK, using the formula: Incorporation % = [H/L]median/(1 + [H/L]median) ×100. The 
heavy/light (H/L) SILAC ratios are determined by analysing the ion chromatograms of the heavy and light peptides as they elute from a C18 column, 
and then calculating the ratio of the areas under XICs curves. The two reference peptides were detected in the tryptic digest of the recombinant 
enzyme extracted from 3 day-old biofilms pulsed with deuterated l-phenylalanine (row 1) or with deuterated l-lysine (row 4), 6 day-old biofilms 
chased with unlabelled phenylalanine (row 2) or with unlabelled lysine (row 5), and 9 day-old biofilms cross pulsed with deuterated l-lysine (row 3) 
or with deuterated l-phenylalanine (row 6)
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labelled amino acids was observed as indicated by the 
ratios in the MS spectra of the correlated heavy and light 
peptides, which is consistent with the quantification 
analysis based on XICs.
To extend our studies on the enzyme regeneration we 
sought to explore whether a further change in labelling 
regiment, past day 6, would continue to differentially 
label the tryptic peptides. At day 6, biofilm that had pre-
viously been administered l-phenylalanine was now 
pulsed with 300 μM of [4,4,5,5-2H4]-l-lysine (Fig. 1, row 
3) and conversely the biofilm that had been administered 
l-lysine was now pulsed with [2,6-2H2]-l-phenylalanine 
(Fig. 1, rows 6). After a further 3 days of maturation, the 
biofilms were harvested and processed for isolation of 
target proteins. Incorporation of labelled lysine into the 
recombinant tryptophan synthase was observed for the 
biofilms initially matured in medium containing phenyla-
lanine and vice versa (see Additional file 1: Figures S3, S4 
for incorporation of [4,4,5,5-2H4]-l-lysine and [2,6-2H2]-
l-phenylalanine). Strikingly, incorporation of labelled 
phenylalanine is observed at  ~90  % for biofilm samples 
in row 6, close to the incorporation level observed for the 
3 day-old biofilms in row 1. Conversely, and in agreement 
with this result, the 9 day-old biofilms in row 3 that had 
been switched to the labelled lysine pulse now showed 
an incorporation level of labelled lysine at  ~43  %, very 
similar to the incorporation level of ~38 % observed for 
the 3 day-old biofilms in row 4. This consistency in label-
ling level reveals that the recombinant enzyme within the 
biofilm continues to be completely replenished without 
perceivable difference in regeneration rates between the 
3 day-old and 9 day-old biofilms. For our assessment of 
the ability of the biofilm samples to catalyse biotransfor-
mation, slides containing biofilms that had matured for 
7 and 9 days were transferred to the reaction buffer sup-
plemented with 5-chloroindole and incubated at 28  °C 
for 24 h in an orbital shaker incubator, as detailed in the 
Methods section. No significant difference was observed 
in terms of overall percentage chlorotryptophan yield 
between biotransformations with 7 and 9  days-old bio-
films (54 vs 59 %; Additional file 1: Figures S7, S8), con-
firming that the generated recombinant tryptophan 
synthases in biofilms are catalytically active. Overall, 
these findings demonstrate that a key contributor to the 
striking and useful longevity of the biocatalytic biofilm is 
the regeneration of the active enzyme.
Conclusions
The urgent demand for the green, sustainable and cost-
effective generation of fine chemicals continues to drive 
the need for new and effective tools for biotransforma-
tions. It is predicted that in the near future almost one-
third of industrial chemical synthesis will be mediated 
by enzymes. To embrace this challenge, not only must 
new enzymes be discovered and developed, but robust 
and generic approaches toward the immobilisation, 
stabilisation and protection of the biocatalyst must be 
established. Readily engineered, single species biofilms 
represent an exciting opportunity as biocatalytic plat-
forms into which genes encoding enzymes that cata-
lyse valuable biotransformations can be introduced. 
The biofilm thereby produces, immobilises and protects 
the biocatalyst. We envisage the possibility of utilising 
this biofilm as a cell factory in which enzymes of inter-
est can be introduced into this platform in a “plug and 
play” fashion for the generation of desired fine chemicals. 
We had previously observed the biofilm possesses strik-
ing biocatalytic longevity, this, we had postulated, was 
likely to be predominantly due to the protection by the 
EPS. Our studies of the lifespan and regeneration of the 
recombinant enzyme, using SILAC, demonstrate that the 
recombinant enzyme is being constantly regenerated in 
the matured biofilm, which we believe is fundamental to 
the longevity of its catalytic activity. Remarkably, we see 
similar levels of fresh label incorporation in a 9 day-old 
biofilm as in a 3 day-old biofilm indicating a similar gen-
eration level of the recombinant enzyme in the developed 
biofilm as in the newly formed biofilm. This result is sur-
prising and exciting as it opens the potential, through the 
careful choice and application of promoters, to switch the 
biocatalytic function of a mature biofilm, and the prod-
ucts that it generates.
Methods
Chemicals, plasmids, bacterial strains and growth 
conditions
Chemicals used in this study were purchased from 
Sigma-Aldrich (St Louis, MO, USA), Fisher Scientific 
(Leicestershire, UK) and Apollo Scientific (Stockport, 
UK), unless stated otherwise. Solvents were purchased 
from Sigma-Aldrich and Fisher Scientific. E. coli K-12 
strain PHL644 (MC4100 malA-kan ompR234) [71] trans-
formed with pSTB7 plasmid containing S. enterica trpA 
and trpB genes and encoding ampicillin resistance [73] is 
employed in this study.
General microbiological work was performed in a 
sterile environment using either a laminar flow hood or 
working around a bunsen flame. A 2  % Distel solution 
was used to sterilise surfaces prior to work. Strains were 
routinely grown in LB (Luria–Bertani) broth (10  g L−1 
NaCl, 10 g L−1 tryptone, 5 g L−1 yeast extract, pH 7.0) or 
agar plates supplemented with ampicillin at a final con-
centration of 100  μg mL−1. For solid medium, agar was 
added at a final concentration of 15 g L−1. For long term 
storage at −80  °C, LB broth containing 20 % of glycerol 
was used.
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For biofilm maturation, M63 medium 
(100  mM  KH2PO4, 15  mM (NH4)2SO4, 0.8  mM 
MgSO4.7H2O, 9  mM FeSO4.2H2O, 17  mM K-succinate, 
10  mM glucose, adjusted to pH 7.0 and supplemented 
with 100 μg mL−1 ampicillin) was used as it has been 
shown to promote curli production. For SILAC experi-
ment, M63 medium was supplemented with either 
[4,4,5,5-2H4]-l-lysine (Sigma-Aldrich, St Louis, MO, 
USA) or in house [2,6-2H2]-l-phenylalanine.
Pulse‑chase SILAC experiments
SILAC was explored as a tool to determine whether or 
not the tryptophan synthase was constantly regener-
ated over time within the biofilm. We set pulse-chase 
experiments in which biofilms were matured in M63 
medium supplemented with stable isotope labelled 
amino acids (pulse phase) and subsequently with unla-
belled amino acids (chase phase). [4,4,5,5-2H4]-l-lysine 
(Sigma-Aldrich) and in house [2,6-2H2]-l-phenylalanine 
were used during the pulse phases and supplemented to 
the medium at final concentrations of 300 and 30  μM, 
respectively. The same concentrations were used for 
unlabelled l-phenylalanine and l-lysine during the chase 
phases.
Biofilms were grown by employing a spin coating 
method as previously described [65] with slight modi-
fication. 75  ×  25  mm microscope slides (VWR Inter-
national, Leicestershire, UK) were cut into 25 ×  25  mm 
squares, sterilized and coated with approximately 1.5 mL 
of 0.1 % w/v poly-l-lysine in water (Sigma-Aldrich). Slides 
were dried in an oven at 60 °C and then transferred into 
9-deep-well plates. A culture of PHL644 pSTB7 [71] was 
streaked onto a LB agar plate with 100 µg/mL of ampicil-
lin and single colonies were inoculated into M63 medium 
containing ampicillin. When the exponential growth 
phase (OD600 of 0.2) was reached, 600  μL aliquots were 
inoculated in 60  mL volume of M63 supplemented with 
either 30  μM of labelled phenylalanine or 300  μM of 
labelled lysine in 250  mL Erlenmeyer flasks, incubated 
at 28  °C, 150  rpm, in an incubator with a 19 mm throw 
until stationary phase (OD600 of 2.0) was reached. Cul-
tures were then centrifuged at 1851g for 15 min and resus-
pended in fresh M63 medium supplemented with either 
30 μM of labelled phenylalanine (triplicate cultures illus-
trated in Fig.  1, rows 1–3) or 300 μM of labelled lysine 
(triplicate cultures illustrated in Fig.  1, rows 4–6) to an 
OD600  ~1.0. 4  mL Aliquots of these suspensions were 
transferred to each well of a 9-deep-well plate contain-
ing a 25 × 25 mm poly-l-lysine coated slide (the labelled 
phenylalanine containing culture was introduced 9 deep 
well plates, illustrated in Fig. 1, rows 1–3 and the labelled 
lysine containing culture introduced into a further 9 deep 
well plates (Fig. 1, rows 4–6), enabling each experiment to 
be carried out in triplicate). Cells were deposited onto the 
slides by centrifuging at 2200g for 15  min using a JS 5.3 
rotor in an Avanti JXN-26 centrifuge (Beckman, Munich, 
Germany), media was removed and 4  mL of fresh M63 
media supplemented with the same labelled amino acid 
(either 30  μM of labelled phenylalanine or 300  μM of 
labelled lysine), as the cells were previously grown in, 
was added. The biofilm samples were incubated at 28  °C 
in an orbital shaker incubator at 50 rpm with a throw of 
19 mm and left to mature. The 18 biofilms were initially 
left to mature in the two sets of labelled M63 media for 
3 days (pulse phase). At day 3, three of the samples that 
had been grown in media enriched with labelled phenyla-
lanine and 3 of the samples that had been grown in media 
enriched with labelled lysine were harvested for analysis 
(see next section). Media was removed from all of the 
remaining 12 samples and replaced with 4  mL of fresh 
media supplemented with either 30 μM of unlabelled 
phenylalanine (Fig. 1, rows 2, 3) or 300 μM of unlabelled 
lysine (Fig. 1, rows 5, 6), these samples were returned to 
incubate at 28 °C in an orbital shaker incubator at 50 rpm 
with a throw of 19 mm. On day 6, six further samples cor-
responding to Fig. 1, rows 2, 5 were harvested; the media 
from the 6 remaining samples removed and replaced with 
4 mL fresh media containing the alternative label i.e. the 
samples that had previously been supplemented with 
phenylalanine were now supplemented with 300 μM of 
labelled lysine (Fig. 1, row 3) and those supplemented pre-
viously with lysine were now supplemented with 30 μM of 
labelled phenylalanine (Fig.  1, row 6). The samples were 
incubated for a further 3 days, under the same conditions 
prior to their harvesting and analysis.
Preparation of protein samples for mass spectrometry, 
LC‑MS detection and analysis on the TripleTOF 5600
At each time point (every 3  days), slides containing the 
biofilms were removed from the deep well plates. Plank-
tonic cells were removed from the biofilm by gentle sub-
mersion and washing in aliquots of phosphate buffer 
(0.1 M KH2PO4, 7  mM serine, 0.1  mM pyridoxal phos-
phate (PLP), adjusted to pH 7.0), having an average of 
optical density (OD600) of 0.65 for 3 day-old biofilm, 0.25 
for 6  day-old biofilm and 0.31 for 9  day-old biofilm in 
4 mL phosphate buffer. Slides were transferred to 50 mL 
centrifuge tubes, immersed in phosphate buffer and the 
biofilms were detached by vigorous vortexing. The empty 
slides were carefully removed and washed and the result-
ant suspended cells were recovered by centrifuging at 
17,000g. The biomass was then suspended in lysis buffer 
(50  mM Tris–HCl, pH 8.0, 25  mM NaCl, 5  % glycerol, 
2.5  mM EDTA, 1  mg/mL lysozyme, Sigma) to which 1 
volume of 2× SDS loading dye (100  mM Tris–HCl, pH 
6.8, 4 % (w/v) SDS, 0.2 % (w/v) bromophenol blue, 20 % 
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(v/v) glycerol, 200  mM DTT) was added; samples were 
then denatured, loaded in a 4–12  % polyacrylamide gel 
(NuPage, Thermo Fisher Scientific). After electropho-
resis, gels were immersed in staining solution (50  % 
methanol, 40 % water, 10 % acetic acid, 0.1 % Coomassie 
Brilliant Blue G-250), followed by destaining. The bands 
of interest were excised from the gel, cut into 1 mm cubes 
and subjected to in-gel digestion, using a ProGest Inves-
tigator in-gel digestion robot (Genomic Solutions, Ann 
Arbor, Michigan, USA) according to standard protocols 
[82]. Briefly, the gel cubes were destained by washing 
with acetonitrile and subjected to reduction and alkyla-
tion before digestion with trypsin at 37 °C. The peptides 
were extracted with 10  % formic acid and concentrated 
down to 20  μL using a SpeedVac (Savant™, Thermo 
Fisher Scientific).
Extracted peptides were separated on an Acclaim Pep-
Map 100 C18 trap and an Acclaim PepMap RSLC C18 
column (Thermo Fisher Scientific), using a nanoLC Ultra 
2D plus loading pump and nanoLC as-2 autosampler 
(Eskigent™, Woodlands, Singapore). The peptides were 
eluted with a gradient of increasing acetonitrile, con-
taining 0.1 % formic acid (5–40 % acetonitrile in 15 min, 
40–95 % in a further 1 min, followed by 95 % acetonitrile 
to clean the column, before reequilibration to 5  % ace-
tonitrile). The eluate was sprayed into a TripleTOF 5600+ 
electrospray tandem mass spectrometer (Sciex, Massa-
chusetts, USA) and analysed in Information Dependent 
Acquisition (IDA) mode, performing cycles of 250  ms 
of MS followed by 100  ms MS analyses on the 15 most 
intense peaks seen by MS.
MS data analysis and calculation of SILAC ratios
The MS data file generated via the ‘Create mgf file’ script 
in PeakView v 2.1 (Sciex, Massachusetts, USA) was ana-
lysed using the Mascot algorithm (Matrix Science, Lon-
don, UK) [79], against the NCBI database [80] with no 
species restriction, trypsin as the cleavage enzyme and 
carbamidomethyl as a fixed modification of cysteines and 
methionine oxidation as a variable modification, to con-
firm the presence of the S. enterica tryptophan synthase 
TrpBA in the E. coli background. The data file was then 
searched against an internal database which includes the 
tryptophan synthase sequence from S. enterica. Addi-
tional variable modifications of [2,6-2H2]-l-phenylala-
nine and [4,4,5,5-2H4]-l-lysine, were added to the search 
parameters. Extracted ion chromatograms (XICs) corre-
sponding to the peaks of interest, identified by the Mas-
cot search, as peptides from tryptophan synthase were 
obtained through PeakView software 2.2. The level of 
incorporation was quantified by calculating the median 
of the labelled (heavy, H)/unlabelled (light, L) ratios 
according to the formula: Incorporation % = [H/L]median/
(1 + [H/L]median) × 100 [78]. Ratios of labelled and unla-
belled peptides were calculated based on the peak area of 
XICs (areas under the curves).
Biofilm‑catalysed biotransformation
Biotransformations were carried out as previously 
described [65, 70] using engineered biofilms that had 
matured for 7 days and 9 days in a potassium phosphate 
reaction buffer (0.1  M KH2PO4, 7  mM Serine, 0.1  mM 
pyridoxal phosphate (PLP), adjusted to pH 7.0). The bio-
film maturation M63 medium was carefully removed 
from the biofilm covered slide by using a syringe. Unad-
hered, planktonic cells were removed from the biofilm by 
gentle resubmersion and washing in aliquots of reaction 
buffer, which was then also removed. Each of washed bio-
film slides removed from the media after 7 and 9 days of 
maturation was then submerged in 4 mL reaction buffer. 
To start the biotransformation, the washed slides coated 
with 7  day-old biofilms (approximately 1.70  mg of total 
cellular protein present in the biofilms) and 9  day-old 
biofilms (~1.83 mg of protein) were submerged in 4 mL 
reaction buffer supplemented with 5 % (v/v) DMSO and 
2 mM 5-chloroindole and incubated in an orbital shaker 
incubator (28 °C, 50 rpm with a 19 mm throw) for 24 h. 
The total protein content of the biofilm (average of 3 
repeats) was determined using a Bradford protein assay 
and a protocol from Li et  al. [83]. 5-chlorotryptophan 
concentrations in biotransformation samples were ana-
lysed using a Waters Acquity UPLC system equipped 
with a Waters Acquity BEH C18 1.7  µm 2.1  ×  50  mm 
column and PDA detector monitoring absorbance at 
280  nm (solvent A: 0.1  % TFA in water, solvent B: ace-
tonitrile. Gradient: 0 min, 5 % B; 0.5 min, 5 % B; 2.0 min, 
50 % B; 0.5 mL/min). For analysis, solutions were taken 
from the biotransformation reaction and centrifuged 
(16,060g, 5 min), and equal volume of methanol was then 
added. The concentration of 5-chlorotryptophan was 
calculated based on a standard curve of UPLC peak area 
versus concentration. Samples of 5-chlorotryptophan of 
known concentration, ranging from 62.5 to 500 µM, were 
analysed by UPLC using the method described above. A 
standard curve of the relationship between UPLC peak 
area (y) and concentration (x) was constructed and the 
relationship between peak area and concentration was 
found to be linear (y = 4866.1x − 596.4). From this stand-
ard curve the unknown concentration of 5-chlorotrypto-
phan in the biotransformation samples was determined 
and an estimation of the overall yield (Y) was calculated 
(Y % = 5-chlorotryptophan concentration/initial 5-chlo-
roindole concentration). For LC–MS analysis samples 
dissolved in water: methanol 50:50 were separated using 
a Dionex Ultimate 3000 RS system (solvent A: 0.1 % FA 
in water, solvent B: acetonitrile. Gradient: 0 min, 5 % B; 
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0.5 min, 5 % B; 5 min, 37.5 % B; 5.1 min, 90 % B; 7 min, 
90 % B; 0.35 mL/min), ionised using a H-ESI source (pos-
itive ion mode, 3.5  kV, heater 325  °C, capillary 350  °C, 
S-lens RF 47 %, sheath gas 55, auxillary gas 20, sweep gas 
2) and analysed using a Thermo Fisher Orbitrap Velos 
Pro (30,000 resolution, 100–800 m/z).
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